Cargando…
Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone
Kratom is an unregulated herbal supplement that is growing in popularity in the United States. Its primary active ingredients, mitragynine, and 7-hydroxymitragynine, are partial agonists that act on mu- and delta-opioid receptors in the central nervous system, producing analgesia and a sense of euph...
Autores principales: | Arhin, Martin, Mobley, Julian, Hamad, Hamad, Remick, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386870/ https://www.ncbi.nlm.nih.gov/pubmed/37519540 http://dx.doi.org/10.7759/cureus.41146 |
Ejemplares similares
-
Anesthetic Challenges Posed by Heavy Kratom Users
por: Lund, Elisa, et al.
Publicado: (2022) -
Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal
por: Overbeek, Daniel L., et al.
Publicado: (2019) -
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022) -
Superficial Parasternal Intercostal Plane Blocks (SPIB) With Buprenorphine, Magnesium, and Bupivacaine for Management of Pain in Coronary Artery Bypass Grafting
por: Krishnan, Sandeep, et al.
Publicado: (2022) -
Continuation Versus Discontinuation of Buprenorphine in the Perioperative Setting: A Retrospective Study
por: Schuster, Braden, et al.
Publicado: (2022)